Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
The British Journal of Radiology|August 31, 2018
Targeting the vasculature of tumours: combining VEGF pathway inhibitors with radiotherapyChryso Kanthou, Gillian TozerExpert Opinion on Therapeutic Targets|November 22, 2007
Tumour targeting by microtubule-depolymerizing vascular disrupting agentsChryso Kanthou, Gillian M TozerInternational Journal of Experimental Pathology|July 1, 2009
Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologiesChryso Kanthou, Gillian M TozerBlood|March 6, 2002
The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cellsChryso Kanthou, Gillian M TozerBiosensors|July 28, 2023
Wearable Insulin Biosensors for Diabetes Management: Advances and ChallengesSotiria D Psoma, Chryso KanthouNature Reviews. Cancer|June 2, 2005
Disrupting tumour blood vesselsGillian M Tozer, Chryso Kanthou, Bruce C BaguleyPharmaceutical Research|March 10, 2018
Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic LiposomesJasmin Monpara, Chryso Kanthou, Gillian M Tozer, et al.Journal of Cellular Biochemistry|September 24, 2002
Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapyOlga Greco, Gabi U Dachs, Gillian M Tozer, et al.International Journal of Experimental Pathology|June 13, 2002
The biology of the combretastatins as tumour vascular targeting agentsGillian M Tozer, Chryso Kanthou, Charles S Parkins, et al.Acta Biochimica Polonica|September 3, 2011
Cardiac endothelial cells isolated from mouse heart - a novel model for radiobiologyKarol Jelonek, Anna Walaszczyk, Dorota Gabryś, et al.Pageof 3